Candel Therapeutics Stock (NASDAQ: CADL) stock price, news, charts, stock research, profile.
You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.
Other companies in Candel Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN) and Precigen (NASDAQ:PGEN).
Candel Therapeutics has a consensus price target of $14.43.
The stock price for Candel Therapeutics (NASDAQ: CADL) is $11.75 last updated February 21, 2025 at 7:54 PM EST.
There are no upcoming dividends for Candel Therapeutics.
Candel Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Candel Therapeutics.
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.